Literature DB >> 30167880

Risk factors of suicidal ideation in Huntington's disease: literature review and data from Enroll-HD.

Philipp Honrath1,2, Imis Dogan1,2, Olga Wudarczyk3,4, Katharina S Görlich3,4, Mikhail Votinov3,4, Cornelius J Werner1,5, Beate Schumann1,2, Rena T Overbeck1,2, Jörg B Schulz1,2, Bernhard G Landwehrmeyer6, Raquel E Gur7, Ute Habel3,4, Kathrin Reetz8,9.   

Abstract

Suicide is a leading cause of death in Huntington's disease (HD), following pneumonia. Up to one-fifth of individuals with HD report suicidal ideation. Identifying the risk factors of suicidal ideation in this clinical population is thus pivotal. Here, we review the literature on prevalence rates and risk factors of suicidal ideation in premanifest and manifest patients and re-evaluate them using the largest currently existing clinical dataset from the ongoing observational study "Enroll-HD" (N = 5709). Large scale studies yielded important insights regarding suicidal ideation in HD. However, estimated prevalence rates vary among studies and risk factors are still poorly understood. According to the Enroll-HD data, pre- and manifest disease stages are associated with current (5.8-10%) and a history of suicidal ideation (18.6-30.9%). Throughout the course of HD, a history of suicidal ideation and the presence of depressive symptoms were strongly associated with current suicidal ideation. However, while for premanifest individuals, socio-demographics and activities of daily living appear to be important, in manifest patients, suicidal ideation is more closely linked to anxiety, irritability, psychosis, and apathy. These results highlight the importance of treating depressive symptoms in patients with HD and addressing potential suicidal ideation during clinical monitoring. The relevance of risk factors may differ among premanifest and manifest patients.

Entities:  

Keywords:  Depression; Enroll-HD; Huntington’s disease; Risk factors; Suicidal ideation

Mesh:

Year:  2018        PMID: 30167880     DOI: 10.1007/s00415-018-9013-6

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  31 in total

1.  Preventing suicide through improved training in suicide risk assessment and care: an American Association of Suicidology Task Force report addressing serious gaps in U.S. mental health training.

Authors:  William M Schmitz; Michael H Allen; Barry N Feldman; Nina J Gutin; Danielle R Jahn; Phillip M Kleespies; Paul Quinnett; Skip Simpson
Journal:  Suicide Life Threat Behav       Date:  2012-04-11

2.  Critical periods of suicide risk in Huntington's disease.

Authors:  Jane S Paulsen; Karin Ferneyhough Hoth; Carissa Nehl; Laura Stierman
Journal:  Am J Psychiatry       Date:  2005-04       Impact factor: 18.112

3.  Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY.

Authors:  Michael Orth; O J Handley; C Schwenke; S Dunnett; E J Wild; S J Tabrizi; G B Landwehrmeyer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-11-19       Impact factor: 10.154

4.  Behavioral changes in Huntington Disease.

Authors:  D Craufurd; J C Thompson; J S Snowden
Journal:  Neuropsychiatry Neuropsychol Behav Neurol       Date:  2001 Oct-Dec

Review 5.  The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis.

Authors:  Tamara Pringsheim; Katie Wiltshire; Lundy Day; Jonathan Dykeman; Thomas Steeves; Nathalie Jette
Journal:  Mov Disord       Date:  2012-06-12       Impact factor: 10.338

6.  Suicide risk in Huntington's disease.

Authors:  L Di Maio; F Squitieri; G Napolitano; G Campanella; J A Trofatter; P M Conneally
Journal:  J Med Genet       Date:  1993-04       Impact factor: 6.318

7.  Suicide in Hungarian Huntington's disease patients.

Authors:  Laszlo Baliko; Bela Csala; Jozsef Czopf
Journal:  Neuroepidemiology       Date:  2004 Sep-Oct       Impact factor: 3.282

Review 8.  Psychopathology in verified Huntington's disease gene carriers.

Authors:  E van Duijn; E M Kingma; R C van der Mast
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2007       Impact factor: 2.198

9.  Characterization of a large group of individuals with huntington disease and their relatives enrolled in the COHORT study.

Authors:  E Ray Dorsey
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

Review 10.  Risk Estimates and Risk Factors Related to Psychiatric Inpatient Suicide-An Overview.

Authors:  Trine Madsen; Annette Erlangsen; Merete Nordentoft
Journal:  Int J Environ Res Public Health       Date:  2017-03-02       Impact factor: 3.390

View more
  3 in total

1.  Loss-of-Huntingtin in Medial and Lateral Ganglionic Lineages Differentially Disrupts Regional Interneuron and Projection Neuron Subtypes and Promotes Huntington's Disease-Associated Behavioral, Cellular, and Pathological Hallmarks.

Authors:  Mark F Mehler; Jenna R Petronglo; Eduardo E Arteaga-Bracho; Maria E Gulinello; Michael L Winchester; Nandini Pichamoorthy; Stephen K Young; Christopher D DeJesus; Hifza Ishtiaq; Solen Gokhan; Aldrin E Molero
Journal:  J Neurosci       Date:  2019-01-09       Impact factor: 6.167

2.  Validation of Neuro-QoL and PROMIS Mental Health Patient Reported Outcome Measures in Persons with Huntington Disease.

Authors:  Noelle E Carlozzi; Siera Goodnight; Anna L Kratz; Julie C Stout; Michael K McCormack; Jane S Paulsen; Nicholas R Boileau; David Cella; Rebecca E Ready
Journal:  J Huntingtons Dis       Date:  2019

3.  Risk factors for suicidality in Huntington disease: An analysis of the 2CARE clinical trial.

Authors:  Andrew McGarry; Michael P McDermott; Karl Kieburtz; Wai Lun Alan Fung; Elizabeth McCusker; Jing Peng; Elisabeth A de Blieck; Merit Cudkowicz
Journal:  Neurology       Date:  2019-03-08       Impact factor: 9.910

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.